Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease

被引：44
作者：
Sullivan, AM
OpackaJuffry, J
Hotten, G
Pohl, J
Blunt, SB
机构：
[1] HAMMERSMITH HOSP,MRC,CYCLOTRON UNIT,LONDON W12 0NN,ENGLAND
[2] BIOPHARM GMBH,D-69115 HEIDELBERG,GERMANY
来源：
NEUROSCIENCE LETTERS | 1997年 / 233卷 / 2-3期
关键词：
growth/differentiation factor 5; neuroprotection; nigrostriatal lesion; 6-hydroxydopamine; dopamine; Parkinson's disease; positron emission tomography;
D O I：
10.1016/S0304-3940(97)00623-X
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Growth/differentiation factor 5 (GDF5), a novel member of the transforming growth factor beta superfamily, promotes the survival of dopaminergic neurones in vitro. We present here the first evidence for a neuroprotective action of GDF5 in vivo. We investigated the effects of intracerebral administration of GDF5 on a rat model of Parkinson's disease. GDF5 was administered just above the substantia nigra and into the lateral ventricle immediately before ipsilateral injection of 6-hydroxydopamine into the medial forebrain bundle. GDF5 prevented the development of amphetamine-induced rotations and preserved the integrity of striatal dopaminergic nerve terminals, as measured by positron emission tomography. Post-mortem studies showed that GDF5 spared dopamine levels in the striatum and tyrosine hydroxylase positive neurones in the midbrain. This study suggests that GDF5 has potential for the treatment of Parkinson's disease. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码：73 / 76
页数：4
相关论文
共 50 条
[21]   Degeneration of nigrostriatal dopaminergic neurons in an experimental model of the early clinical stage of Parkinson’s disease [J].
A. A. Kolacheva ;
E. A. Kozina ;
E. V. Volina ;
M. V. Ugryumov .
Neurochemical Journal, 2014, 8 :184-192
[22]   Degeneration of nigrostriatal dopaminergic neurons in an experimental model of the early clinical stage of Parkinson's disease [J].
Kolacheva, A. A. ;
Kozina, E. A. ;
Volina, E. V. ;
Ugryumov, M. V. .
NEUROCHEMICAL JOURNAL, 2014, 8 (03) :184-192
[23]   Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson's disease [J].
Ishibashi, K. ;
Kanemaru, K. ;
Saito, Y. ;
Murayama, S. ;
Oda, K. ;
Ishiwata, K. ;
Mizusawa, H. ;
Ishii, K. .
ACTA NEUROLOGICA SCANDINAVICA, 2010, 122 (01) :46-51
[24]   STAT3 protects dopaminergic neurons against degeneration in animal model of Parkinson's disease [J].
Smit, Rupert D. ;
Ghosh, Biswarup ;
Campion III, Thomas J. ;
Stingel, Rachel ;
Lavell, Emily ;
Hooper, Robert ;
Fan, Xiaoxuan ;
Soboloff, Jonathan ;
Smith, George M. .
BRAIN RESEARCH, 2024, 1824
[25]   Dopaminergic urethral closure mechanisms in a rat model of Parkinson's disease [J].
Ouchi, Mifuka ;
Kitta, Takeya ;
Kanno, Yukiko ;
Higuchi, Madoka ;
Togo, Mio ;
Takahashi, Yui ;
Moriya, Kimihiko ;
Shinohara, Nobuo .
NEUROUROLOGY AND URODYNAMICS, 2019, 38 (05) :1203-1211
[26]   A New Approach to Assessing the Extent of Degradation of the Nigrostriatal Dopaminergic System in an Experimental Model of Parkinson’s Disease [J].
Safandeev V.V. ;
Ugrumov M.V. .
Neuroscience and Behavioral Physiology, 2020, 50 (4) :451-458
[27]   Detection of the latent functional insufficiency of dopaminergic neurons in the nigrostriatal system in a chronic model of Parkinson's disease [J].
Safandeev, V. V. ;
Kolacheva, A. A. ;
Ivanov, D. E. ;
Ugryumov, M. V. .
NEUROCHEMICAL JOURNAL, 2017, 11 (04) :290-295
[28]   Detection of the latent functional insufficiency of dopaminergic neurons in the nigrostriatal system in a chronic model of Parkinson’s disease [J].
V. V. Safandeev ;
A. A. Kolacheva ;
D. E. Ivanov ;
M. V. Ugryumov .
Neurochemical Journal, 2017, 11 :290-295
[29]   NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease [J].
Crocker, SJ ;
Wigle, N ;
Liston, P ;
Thompson, CS ;
Lee, CJ ;
Xu, DG ;
Roy, S ;
Nicholson, DW ;
Park, DS ;
MacKenzie, A ;
Korneluk, RG ;
Robertson, GS .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2001, 14 (02) :391-400
[30]   Demethylenetetrahydroberberine protects dopaminergic neurons in a mouse model of Parkinson's disease [J].
Wen Jing ;
Zhang Yuan-Qiang ;
Liu Dong-Qing ;
Yao Xu-Tao ;
Jiang Hua ;
Zhang Yu-Bin .
CHINESE JOURNAL OF NATURAL MEDICINES, 2022, 20 (02) :111-119
12345